IgH SHM analysis of fetal spleen B cells
| B cells | Total unique sequences | Mutated sequencesa | % of mutation frequencyb | Mutation range |
|---|---|---|---|---|
| Donor 1 IgD+CD27− | 11 | 0 | – | – |
| Donor 1 IgD+CD27+ | 18 | 3 (17%) | 2.3 | 5–7 |
| Donor 2 IgD+CD27+ | 19 | 3 (16%) | 2.7 | 5–11 |
| Donor 3 IgD+CD27+ | 29 | 6 (21%) | 2.4 | 3–12 |
| B cells | Total unique sequences | Mutated sequences | % of mutation frequency | Mutation range |
|---|---|---|---|---|
| Donor 1 IgD+CD27− | 11 | 0 | – | – |
| Donor 1 IgD+CD27+ | 18 | 3 (17%) | 2.3 | 5–7 |
| Donor 2 IgD+CD27+ | 19 | 3 (16%) | 2.7 | 5–11 |
| Donor 3 IgD+CD27+ | 29 | 6 (21%) | 2.4 | 3–12 |
Only unique rearrangements were considered for analysis. Sequences scored as mutated contained three or more mutations (≥1% mutation frequency). In brackets is the frequency of mutated sequences among all sequences.
The percentage of point mutations among the total number of sequenced nucleotides of mutated sequences.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.